We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Tina Thethi

Tina Thethi MD, MPH, FACE

Endocrinologist, AdventHealth Diabetes Institute, and Associate Investigator, Translational Research Institute, AdventHealth, Orlando, Florida

Tina Kaur Thethi MD, MPH, FACE, is an Endocrinologist at the AdventHealth Diabetes Institute, as well as Associate Investigator at the AdventHealth Translational Research Institute in Orlando, Florida. Dr. Thethi’ s research interests center around obesity, type 2 diabetes and it’s complications with a focus on diabetic kidney disease. To better understand the pathogenesis of diabetic kidney disease and find biomarkers that identify diabetic kidney disease earlier is a key goal of Dr. Thethi’ s research career. Other areas of interest include studying gender and racial differences in obesity, endothelial dysfunction, and cardiovascular disease in type 2 diabetes mellitus.

https://www.ncbi.nlm.nih.gov/myncbi/tina.thethi.1/bibliography/public/

Disclosures

Dr. Theti is on the speaker's bureau for Novo Nordisk and is one of the National Leads for the study SOUL (Novo Nordisk).